Figure 1 (Ipratropium Fig1)
Ipratropium Bromide Solution
Product Images NDC 65862-905
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 65862-905). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label-principal Display Panel (0.02% (0.5 mg/2.5 mL))
This is a description for Ipratropium Bromide Inhalation Solution in a unit dose vial. It is used for oral inhalation only and should not be injected. It contains 0.02% Ipratropium Bromide and comes in a pack of 60 x 2.5mL sterile unit dose vials, contained in 2 x 30 vial pouches. Each vial has an adjusted pH of 3.4 (3t 4) with hydrochloric acid. The product is distributed by Aurobindo Pharma USA, Inc. and made in India. The provided NDC code is 65862-905-60.*
Figure 2 (Ipratropium Fig2)
Figure 3 (Ipratropium Fig3)
Package Label-principal Display Panel (0.02% (0.5 mg/2.5 mL))
This is a description of a medication called Ipratropium Bromide Inhalation Solution. It is contained in a 2.5mL sterile unit dose vial made of low-density polyethylene. The medication is intended for oral inhalation only and has a prescribed dosage that is not included. Each vial contains 25mL of the medication, which is isotonic sterile aqueous solution containing sodium chloride and has an adjusted pH of 3.4. The medication is only for oral inhalation and should not be injected. The medication should be stored in temperatures between 15-30℃ and should be protected from light. It is provided with a set of instructions for using medication for the patients. The distributor for the medication is Aurobindo Pharma USA Inc.*
Package Label-principal Display Panel (0.02% (0.5 mg/2.5 mL))
This is a prescription drug called Ipratropium Bromide Inhalation Solution for oral inhalation only that comes in 25 sterile unit dose vials. Each vial contains 2.5 mL of the solution that consists of Ipratropium Bromide USP 0.02%, preservative e, isotonic sterile aqueous solution containing sodium chloride. The drug is stored between 15° and 30°C and needs to be protected from light. The packaging includes instructions for use for the patient and the product is distributed by Aurobindo Pharma USA, Inc. in New Jersey, USA.*
Package Label-principal Display Panel (0.02% (0.5 mg/2.5 mL))
This is a prescription medication called Ipratropium Bromide Inhalation Solution, which comes in a box of 30 sterile vials. The medication is for oral inhalation only and not for injection. Each vial contains 2.5 mL of the solution. The solution contains sodium chloride and the drug itself, Ipratropium Bromide USP 0.02%, and has been adjusted to pH 3.4. It is suggested to store this medication, unused vials in the provided protection pouch at temperatures between 15° and 30°C (59° and 86°F). The patient should not use the medication without consulting a physician, and the pharmacist should dispense the medication with solution attached. The packaging has been labeled with the necessary identification numbers and contact information.*
Package Label.principal Display Panel (0.02% (0.5 mg/2.5 mL))
This is a description for a medication called Ipratropium Bromide Inhalation Solution. The medication is stored in individual vials, each one containing 2.5 mL of a preservative-free, sterile aqueous solution that is specially formulated with isotonic sodium chloride. This medicine is intended for oral inhalation only and not for injection. It is distributed by Aurobindo Pharma USA and made in India. The NDC number for this medication is 65862-905-03.*
Package Label.principal Display Panel (0.02% (0.5 mg/2.5 mL))
This is a prescription medication labeled NDG 65862-905-25 containing Ipratropium Bromide Inhalation Solution for oral inhalation only. It comes in 2.5mL sterile unit dose vials with a concentration of 0.02% (0.5mg/2.5mL). The solution is preservative-free, isotonic sterile aqueous and the usual dosage is indicated in the prescribing information. It is not for injection and should be stored between 15°C and 30°C; protect from light and store unused vials in the foil pouch. The patient’s instructions for use must be detached from the package insert and dispensed with the solution. The medication is distributed by Aurobindo Pharma USA and contains no non-English characters.*
Package Label-principal Display Panel (0.02% (0.5 mg/2.5 mL))
Ipratropium Bromide Inhalation Solution is a prescription medicine available in 30 units of 2.5 mL Sterile Unit Dose Vials. Each vial contains 2.5 mL of Isotonic sterile aqueous solution and sodium chloride, adjusted to pH 3.4 (310 4) with hydrochloric acid. It is used for oral inhalation only, not for injection. The usual dosage can be seen in the accompanying prescribing information. This medicine should be stored between 15° and 30°C (59° and 86°F) to protect from light. The patient's instruction for use is enclosed separately and should be dispensed with the solution. The Ipratropium Bromide Inhalation Solution is manufactured in India and distributed by the Aurobindo Pharma USA, Inc.*
Ipratropium Bromide Monohydrate Chemical Structure (Ipratropium Str)
This is a chemical compound called ipratropium bromide monohydrate with a molecular weight of 4304. No further information is available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
